Actavis' Colitis Drug ANDA Triggers Patent Suit
By Jacob Batchelor ( February 23, 2015, 5:39 PM EST) -- Cosmo Technologies Ltd. and a Salix Pharmaceuticals Ltd. subsidiary have sued in New Jersey federal court to block Actavis Inc.'s abbreviated new drug application for a generic version of the colitis treatment Uceris....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.